Cell-Type Specific Interrogation of CeA Drd2 Neurons to Identify Targets for Pharmacological Modulation of Fear Extinction

Behavioral and molecular characterization of cell-type specific populations governing fear learning and behavior is a promising avenue for the rational identification of potential therapeutics for fear-related disorders. Examining cell-type specific changes in neuronal translation following fear learning allows for targeted pharmacological intervention during fear extinction learning, mirroring possible treatment strategies in humans. Here we identify the central amygdala (CeA) Drd2-expressing population as a novel fear-supporting neuronal population that is molecularly distinct from other, previously identified, fear-supporting CeA populations. Sequencing of actively translating transcripts of Drd2 neurons using translating ribosome affinity purification (TRAP) technology identifies mRNAs that are differentially regulated following fear learning. Differentially expressed transcripts with potentially targetable gene products include Npy5r, Rxrg, Adora2a, Sst5r, Fgf3, Erbb4, Fkbp14, Dlk1, and Ssh3. Direct pharmacological manipulation of NPY5R, RXR, and ADORA2A confirms the importance of this cell population and these cell-type specific receptors in fear behavior. Furthermore, these findings validate the use of functionally identified specific cell populations to predict novel pharmacological targets for the modulation of emotional learning.

[1]  Arun Sharma,et al.  Current Drug Targets in Obesity Pharmacotherapy - A Review. , 2017, Current drug targets.

[2]  C. Müller,et al.  Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation , 2017, Neuropharmacology.

[3]  T. Skaar,et al.  Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson. , 2017, Pharmacogenomics.

[4]  S. Tonegawa,et al.  Basolateral to Central Amygdala Neural Circuits for Appetitive Behaviors , 2017, Neuron.

[5]  Andreas Lüthi,et al.  A competitive inhibitory circuit for selection of active and passive fear responses , 2017, Nature.

[6]  K. Ressler,et al.  Bridging the Gap: Towards a cell-type specific understanding of neural circuits underlying fear behaviors , 2016, Neurobiology of Learning and Memory.

[7]  M. E. Pedreira,et al.  The fate of memory: Reconsolidation and the case of Prediction Error , 2016, Neuroscience & Biobehavioral Reviews.

[8]  W. Oertel,et al.  Current and experimental treatments of Parkinson disease: A guide for neuroscientists , 2016, Journal of neurochemistry.

[9]  M. Kaster,et al.  Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory , 2016, Neuropsychopharmacology.

[10]  D. F. Albeanu,et al.  Central Amygdala Somatostatin Neurons Gate Passive and Active Defensive Behaviors , 2016, The Journal of Neuroscience.

[11]  P. Pal,et al.  Genetic substrates of psychosis in patients with Parkinson's disease: A critical review , 2016, Journal of the Neurological Sciences.

[12]  Yun-jie Wang,et al.  The Association Between Genetic Variants in the Dopaminergic System and Posttraumatic Stress Disorder , 2016, Medicine.

[13]  Paul H. Wen,et al.  Effect of LXR/RXR agonism on brain and CSF Aβ40 levels in rats , 2016, F1000Research.

[14]  C. Gerfen,et al.  Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala , 2016, Molecular Psychiatry.

[15]  J. McCall,et al.  CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety , 2015, Neuron.

[16]  Sung Han,et al.  Elucidating an Affective Pain Circuit that Creates a Threat Memory , 2015, Cell.

[17]  S. E. Hammack,et al.  Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: Implication for the sensory and behavioral effects of pain , 2014, Neuropharmacology.

[18]  B. Dias,et al.  A Role for Tac2, NkB, and Nk3 Receptor in Normal and Dysregulated Fear Memory Consolidation , 2014, Neuron.

[19]  B. Bradley,et al.  A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. , 2014, The American journal of psychiatry.

[20]  Paul Greengard,et al.  Cell type–specific mRNA purification by translating ribosome affinity purification (TRAP) , 2014, Nature Protocols.

[21]  A. J. van Rozen,et al.  Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum , 2014, Front. Neuroanat..

[22]  K. Lattal,et al.  Dopamine and extinction: A convergence of theory with fear and reward circuitry , 2014, Neurobiology of Learning and Memory.

[23]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[24]  J. Girault,et al.  Spatial distribution of D1R- and D2R-expressing medium-sized spiny neurons differs along the rostro-caudal axis of the mouse dorsal striatum , 2013, Front. Neural Circuits.

[25]  Shalini Jain,et al.  Novel designer receptors to probe GPCR signaling and physiology. , 2013, Trends in pharmacological sciences.

[26]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[27]  T. Daigle,et al.  A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons , 2013, Neuropsychopharmacology.

[28]  Charles D. Kopec,et al.  Experience-dependent modification of a central amygdala fear circuit , 2013, Nature Neuroscience.

[29]  J. Girault,et al.  Characterization of dopamine D1 and D2 receptor‐expressing neurons in the mouse hippocampus , 2012, Hippocampus.

[30]  K. Fuxe,et al.  Distribution of dopamine D2-like receptors in the rat amygdala and their role in the modulation of unconditioned fear and anxiety , 2012, Neuroscience.

[31]  B. Roth,et al.  Remote Control of Neuronal Signaling , 2011, Pharmacological Reviews.

[32]  David J. Anderson,et al.  Genetic dissection of an amygdala microcircuit that gates conditioned fear , 2010, Nature.

[33]  Michael B. Stadler,et al.  Encoding of conditioned fear in central amygdala inhibitory circuits , 2010, Nature.

[34]  雪岡 日出男.  新規ニューロペプチドY Y5受容体アンタゴニストS-2367の抗肥満作用 , 2010 .

[35]  Xavier Estivill,et al.  Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. , 2010, Journal of psychiatric research.

[36]  C. Freitag,et al.  Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. , 2010, Journal of psychiatric research.

[37]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[38]  K. Fuxe,et al.  Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis , 2010, Progress in Neurobiology.

[39]  Jian Hua Li,et al.  A chemical-genetic approach to study G protein regulation of β cell function in vivo , 2009, Proceedings of the National Academy of Sciences.

[40]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[41]  M. Nicolelis,et al.  Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors , 2009, Neuron.

[42]  Paul Pavlidis,et al.  Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model , 2008, Nature Genetics.

[43]  Charles R. Gerfen,et al.  Targeting Cre Recombinase to Specific Neuron Populations with Bacterial Artificial Chromosome Constructs , 2007, The Journal of Neuroscience.

[44]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[45]  M. Davis,et al.  Mechanisms of fear extinction , 2007, Molecular Psychiatry.

[46]  K. Jacobson,et al.  Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.

[47]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Ponnusamy,et al.  Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. , 2005, Learning & memory.

[49]  Joseph E LeDoux,et al.  New vistas on amygdala networks in conditioned fear. , 2004, Journal of neurophysiology.

[50]  A. McDonald.  Is There an Amygdala and How Far Does It Extend? , 2003, Annals of the New York Academy of Sciences.

[51]  Michael Davis,et al.  Role of the Amygdala in Fear Extinction Measured with Potentiated Startle , 2003, Annals of the New York Academy of Sciences.

[52]  A E Pollack,et al.  Anatomy, physiology, and pharmacology of the basal ganglia. , 2001, Neurologic clinics.

[53]  L. Bourgeais,et al.  Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA‐L study in the rat , 2001, The European journal of neuroscience.

[54]  Hiroshi Kase,et al.  Rescue of Locomotor Impairment in Dopamine D2 Receptor-Deficient Mice by an Adenosine A2A Receptor Antagonist , 2000, The Journal of Neuroscience.

[55]  F. Guarraci,et al.  The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. , 2000, Behavioral neuroscience.

[56]  Koji Yamada,et al.  Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP , 1999, Psychopharmacology.

[57]  Hiroshi Kase,et al.  Adenosine A2A antagonists with potent anti-cataleptic activity , 1997 .

[58]  F. Mascagni,et al.  Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat , 1996, Neuroscience.

[59]  M. Fanselow,et al.  The Amygdala and Fear Conditioning: Has the Nut Been Cracked? , 1996, Neuron.

[60]  B. Bloch,et al.  D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.

[61]  Michael Davis,et al.  Sensitization of the startle reflex by footshock: blockade by lesions of the central nucleus of the amygdala or its efferent pathway to the brainstem. , 1989, Behavioral neuroscience.

[62]  A. McDonald,et al.  Cytoarchitecture of the central amygdaloid nucleus of the rat , 1982, The Journal of comparative neurology.

[63]  Stephen Maren,et al.  Stress and Fear Extinction , 2016, Neuropsychopharmacology.

[64]  Katherine R. Luking,et al.  Mechanisms Underlying Motivational Deficits in Psychopathology: Similarities and Differences in Depression and Schizophrenia. , 2016, Current topics in behavioral neurosciences.

[65]  M. Dawson,et al.  The retinoid X receptors and their ligands. , 2012, Biochimica et biophysica acta.

[66]  Y. Smith,et al.  Microcircuitry of the direct and indirect pathways of the basal ganglia. , 1998, Neuroscience.